Enriquez, Alan D <br/><br/>
Determinants of Heparin Dosing and Complications in Patients Undergoing Left Atrial Ablation on Uninterrupted Rivaroxaban.  [electronic resource] 

 -  Pacing and clinical electrophysiology : PACE  Feb 2017 
 - 183-190 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1540-8159 
<br/><br/><label>Standard No.: </label>10.1111/pace.13013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Anticoagulants--administration & dosage<br/>Atrial Fibrillation--epidemiology<br/>Body Weight<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination--statistics & numerical data<br/>Female<br/>Fibrinolytic Agents--administration & dosage<br/>Heart Atria--drug effects<br/>Heparin--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Postoperative Complications--epidemiology<br/>Premedication--statistics & numerical data<br/>Prevalence<br/>Risk Factors<br/>Rivaroxaban--administration & dosage<br/>Thromboembolism--epidemiology<br/>Treatment Outcome<br/>United States--epidemiology